Press Releases and News

Biotherapeutics Analytical Summit

April 3, 2018

The summit, which was in its 9th year, focused on empowering innovation to advance molecules from discovery through commercialization, using the right tools and techniques. Biophysicists, structural biologists, and others attended this conference to discuss advances, hear case studies and learn new applications of biotherapeutics technologies in the endeavor of developing new drug leads. We … “Biotherapeutics Analytical Summit”

READ MORE

Biophysical Society: educating biophysicists on cutting edge technologies in protein characterization

March 12, 2018

BPS18 was the 62nd annual meeting for the Biophysical Society, one of the largest gathering of biophysicists in the world. There were more than 7,000 researchers from over 45 countries in attendance. The event is focused on the professional development of biophysicists, so there was a real interest in learning about new techniques for protein … “Biophysical Society: educating biophysicists on cutting edge technologies in protein characterization”

READ MORE

Celebrating new analytical techniques to accelerate the development of life saving biotherapeutics at PepTalk

February 28, 2018

PepTalk: The Protein Science Week is one of the largest annual gatherings of protein science researchers in the world. The RedShiftBio team attended in January to present a poster on Thermal Denaturation Analysis of Bovine Serum Albumin by Microfluidic Modulation Spectroscopy. We got to meet with many of the nearly 1,300 experts from academia, biotech … “Celebrating new analytical techniques to accelerate the development of life saving biotherapeutics at PepTalk”

READ MORE

RedShiftBio Inc. Completes $11.0 million Series C Financing

March 14, 2017

RedShift BioAnalytics, Inc., an innovative provider of bioanalytical instrumentation for the research, development and manufacturing of protein therapeutic drugs, today announced the closing of the Company’s $11.0 million Series C Preferred Stock financing.

READ MORE